Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Field

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Health Psychology|April 24, 2016
Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatologyAnna Barata, Brian D Gonzalez, Steven K Sutton, et al.
Journal of Hematology & Oncology|October 8, 2010
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemiaJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Infliximab for managing steroid-refractory acute graft-versus-host diseaseJoseph Pidala, Jongphil Kim, Teresa Field, et al.
Haematologica|May 14, 2011
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoidsJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
American Journal of Hematology|October 5, 2010
Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institutionTaiga Nishihori, Janelle Perkins, Jongphil Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2014
Pretransplantation 5-azacitidine in high-risk myelodysplastic syndromeTaiga Nishihori, Janelle Perkins, Asmita Mishra, et al.
Leukemia Research|January 22, 2013
Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification modelsVu H Duong, Jeffrey E Lancet, Ezzideen Alrawi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2010
A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxisJanelle Perkins, Teresa Field, Jongphil Kim, et al.
Journal of Psychosomatic Research|January 24, 2016
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patientsJulie M Cessna, Heather S L Jim, Steven K Sutton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2011
Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemiaStella Santarone, Joseph Pidala, Marta Di Nicola, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Health Psychology|April 24, 2016
Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatologyAnna Barata, Brian D Gonzalez, Steven K Sutton, et al.
Journal of Hematology & Oncology|October 8, 2010
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemiaJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Infliximab for managing steroid-refractory acute graft-versus-host diseaseJoseph Pidala, Jongphil Kim, Teresa Field, et al.
Haematologica|May 14, 2011
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoidsJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
American Journal of Hematology|October 5, 2010
Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institutionTaiga Nishihori, Janelle Perkins, Jongphil Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2014
Pretransplantation 5-azacitidine in high-risk myelodysplastic syndromeTaiga Nishihori, Janelle Perkins, Asmita Mishra, et al.
Leukemia Research|January 22, 2013
Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification modelsVu H Duong, Jeffrey E Lancet, Ezzideen Alrawi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2010
A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxisJanelle Perkins, Teresa Field, Jongphil Kim, et al.
Journal of Psychosomatic Research|January 24, 2016
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patientsJulie M Cessna, Heather S L Jim, Steven K Sutton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2011
Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemiaStella Santarone, Joseph Pidala, Marta Di Nicola, et al.
Pageof 4